Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 7—July 2014
Research

Changes in Capsule and Drug Resistance of Pneumococci after Introduction of PCV7, Japan, 2010–2013

Naoko Chiba, Miyuki Morozumi, Michi Shouji, Takeaki Wajima, Satoshi Iwata, Kimiko UbukataComments to Author , and the Invasive Pneumococcal Diseases Surveillance Study Group
Author affiliations: Keio University School of Medicine, Tokyo, Japan (N. Chiba, M. Morozumi, S. Iwata, K. Ubukata); Kitasato University, Tokyo (N. Chiba, M. Morozumi, K. Ubukata); National Cancer Center Hospital, Tokyo (M. Shouji); Tokyo University of Pharmacy and Life Sciences, Tokyo (T. Wajima)

Main Article

Figure 2

Changes in serotype number and penicillin resistance according to genotype, Japan, April 2010–March 2013. gPSSP, genotypic penicillin-susceptible Streptococcus pneumoniae; gPISP, genotypic penicillin-intermediate resistant S. pneumoniae; gPRSP, penicillin-resistant S. pneumoniae. The parentheses express abnormal pbp gene mediating penicillin resistance. 2010 indicates first surveillance period (April 2010–March 2011); 2011 indicates second surveillance period (April 2011–March 2012); 2012 indica

Figure 2. Changes in serotype number and penicillin resistance according to genotype, Japan, April 2010–March 2013gPSSP, genotypic penicillin-susceptible Streptococcus pneumoniae; gPISP, genotypic penicillin-intermediate resistant Spneumoniae; gPRSP, penicillin-resistant SpneumoniaeThe parentheses express abnormal pbp gene mediating penicillin resistance2010 indicates first surveillance period (April 2010–March 2011); 2011 indicates second surveillance period (April 2011–March 2012); 2012 indicates third surveillance period (April 2012–March 2013).

Main Article

Page created: June 17, 2014
Page updated: June 17, 2014
Page reviewed: June 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external